這個影片是介紹EGCG會與FTO蛋白互相拮抗來抑制脂肪細胞的過程。
參考文獻：
https://en.wikipedia.org/wiki/Tea
https://en.wikipedia.org/wiki/Quercetin
https://en.wikipedia.org/wiki/Catechin
https://en.wikipedia.org/wiki/Epigallocatechin_gallate
Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernández, T. Y., Cianciosi, D., Reboredo-Rodriguez, P., … & Battino, M. (2020). Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology advances, 38, 107322.
Dai, W., Ruan, C., Zhang, Y., Wang, J., Han, J., Shao, Z., … & Liang, J. (2020). Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review. Journal of Functional Foods, 65, 103732.
Wu, R., Yao, Y., Jiang, Q., Cai, M., Liu, Q., Wang, Y., & Wang, X. (2018). Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m 6 A-YTHDF2-dependent manner. International journal of obesity, 42(7), 1378-1388.
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., … & McCarthy, M. I. (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316(5826), 889-894.
